SRPT - Sarepta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SRPT is currently covered by 22 analysts with an average price target of $158.79. This is a potential upside of $44.47 (38.9%) from yesterday's end of day stock price of $114.32.

Sarepta Therapeutics's activity chart (see below) currently has 589 price targets and 539 ratings on display. The stock rating distribution of SRPT is 83.06% BUY and 16.94% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.45% with an average time for these price targets to be met of 281.44 days.

Highest price target for SRPT is $230, Lowest price target is $150, average price target is $158.79.

Most recent stock forecast was given by BRIAN SKORNEY from BAIRD on 07-Nov-2024. First documented stock forecast 20-Mar-2013.

Currently out of the existing stock ratings of SRPT, 103 are a BUY (83.06%), 21 are a HOLD (16.94%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$193

$71.39 (58.70%)

$200

6 days ago
(07-Nov-2024)

41/56 (73.21%)

$67.75 (54.09%)

290

Hold

$167

$45.39 (37.32%)

$152

6 days ago
(07-Nov-2024)

6/13 (46.15%)

$41.75 (33.33%)

112

Buy

$150

$28.39 (23.35%)

$103

6 days ago
(07-Nov-2024)

3/5 (60%)

$24.75 (19.76%)

274

Buy

$205

$83.39 (68.57%)

$205

6 days ago
(07-Nov-2024)

12/25 (48%)

$79.75 (63.67%)

355

Buy

$182

$60.39 (49.66%)

$182

23 days ago
(21-Oct-2024)

16/48 (33.33%)

$54.69 (42.96%)

337

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SRPT (Sarepta Therapeutics) average time for price targets to be met?

On average it took 281.44 days on average for the stock forecasts to be realized with a an average price target met ratio 60.45

Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?

DIFEI YANG

Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?

Difei Yang has 23 price targets and 17 ratings on SRPT

Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?

Mani Foroohar with highest potential upside - $108.39

Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?

Robyn Karnauskas with lowest potential downside - -$97.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?